Neovasc (NVCN) Agrees to Sell Tissue Processing Tech to Boston Scientific (BSX) in $75M Deal
Neovasc Inc. (Nasdaq: NVCN) announced that Boston Scientific Corporation (NYSE: BSX), a global medical technology leader, has agreed to acquire ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)